Bioethique Tunisie, 27 Nov 2023 The limited success of amyloid-β-targeting therapies for Alzheimer disease has led to a shift in focus towards the tau protein.
Psiconeurobiologia - Master II Livello, 26 Oct 2023 https://www.nature.com/articles/s41582-023-00883-2